Top Markets
Coin of the day
Lucira Health, Inc. Lucira Health, Inc.

Lucira Health, Inc.

LHDX
Clasificación en acciones #33746
Lucira Health, Inc. is a medical technology enterprise dedicated to the... Lucira Health, Inc. is a medical technology enterprise dedicated to the development and commercialization of diagnostic test kits for infectious diseases. The company has innovated a platform capable of providing molecular testing capabilities. Among its current product offerings is the LUCIRA COVID-19 All-In-One Test Kit, and it is also progressing with the development of diagnostic solutions for influenza A and B viruses. Lucira Health holds a patent license agreement with Eiken Chemical Co., Ltd., alongside technical and manufacturing service agreements with Jabil, Inc. and Jabil MSA, respectively. Founded in 2013, the company operated as DiAssess Inc. until January 2020 when it rebranded to Lucira Health, Inc. Its main offices are situated in Emeryville, California.
Precio por acción
$0.4523
Última sincronización: 2023-03-03
Capitalización bursátil
$6.97M
Cambio (1 día)
-19.23%
Cambio (1 año)
0.00%
País
US
Comercio Lucira Health, Inc. (LHDX)

Categoría

Ratio P/B de Lucira Health, Inc. (LHDX)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Lucira Health, Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Lucira Health, Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
3.7944 -
US
5.423 -
US
2.0146 -
IE
3.072 -
US
4.9725 -
US